bradykinin, des-arg(9)- has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daaka, Y; Guo, R; Leeb-Lundberg, LM; Madden, JF; Taub, JS | 1 |
| Adam, A; Arnold, DM; Blajchman, MA; Davis, I; DiTomasso, J; Dunn, G; Heddle, NM; Lesiuk, L; Molinaro, G; Warkentin, TE; Webert, KE | 1 |
2 other study(ies) available for bradykinin, des-arg(9)- and Cancer of Prostate
| Article | Year |
|---|---|
Bradykinin receptor subtype 1 expression and function in prostate cancer.
Topics: Biopsy; Bradykinin; Bradykinin Receptor Antagonists; Cell Division; Cell Movement; Enzyme Activation; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Prostatic Neoplasms; Receptors, Bradykinin; Signal Transduction | 2003 |
Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage.
Topics: Adenocarcinoma; Aminopeptidases; Angiotensin-Converting Enzyme Inhibitors; Blood Component Transfusion; Blood Preservation; Blood Transfusion, Autologous; Bradykinin; Filtration; Hemodilution; Humans; Hypotension; Kinins; Leukocytes; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms | 2004 |